Lead author: Samir Jaber, s-jaber@chu-montpellier.fr Three part clinical question: Patients: Patients aged >40 and <90 years who were scheduled to undergo laparoscopic or non-laparoscopic elective major abdominal surgery, with an expected duration of surgery greater than two hours and with a preoperative risk index of pulmonary complications of more than 2 (out of a maximum 5). Intervention: Patients were allocated to receive either nonprotective mechanical ventilation with tidal volumes of 10-12 mL/kg predicted body weight with no PEEP and no recruitment manoeuvres, or lung-protective mechanical ventilation with a tidal volume of 6-8 mL/kg predicted body weight, PEEP of 6-8 cm H 2 O, and recruitment manoeuvres every 30 minutes following tracheal intubation. Outcomes: The primary outcome was a composite of major pulmonary and extra-pulmonary complications occurring by day seven after surgery (pneumonia, need for IV/NIV for respiratory failure, sepsis, severe sepsis, septic shock, or death). Secondary outcomes were measured in the 30 days following surgery, again including pulmonary and extra-pulmonary complications as above, as well as the need for intensive care unit (ICU) admission, the duration of ICU and/or hospital stay, and the need for re-operation.
The study design:
The study was a prospective, multi-centre, double-blinded, stratified, parallel-group, randomised controlled trial.
The study patients: As above; 1,803 patients were identified in seven French teaching hospitals between 31 Jan 2011 and 10 Aug 2012, with 1,202 found ineligible, mainly due to a preoperative pulmonary risk index <2. The remainder was screened and 400 eligible patients identified. They were randomised, with 200 patients in each limb of the trial, 100% of whom were followed up for 30 days. Exclusions: Patients who had received mechanical ventilation, or had a history of respiratory failure or sepsis within the two weeks preceding surgery. Those with a BMI >35, with a need for intrathoracic or emergency surgery, and those with progressive neuromuscular illness were also excluded.
Protective ventilation strategies in abdominal surgery 2C02, 2C04
Adoption of a lung-protective ventilation strategy (PEEP and low tidal volume) in patients undergoing abdominal surgery is associated with a reduction in pulmonary and extra-pulmonary complications.
Level of evidence: 1B (single-centre randomised trial with a low risk of bias). The evidence:
Appraised by: A Proffitt, AM Johnston
Protective ventilation was associated with a reduction in major pulmonary and extrapulmonary complications as well as a reduced length of hospital stay (11 vs 13 days, median LOS). There was no difference between the groups with respect to unexpected admissions to ICU (in the 30 days postoperatively), adverse event rates or mortality.
EBM questions 1. Do the methods accurately allow testing of the hypothesis? Yes.
Randomisation and subsequent comparison of the two patient groups reveal similar baseline characteristics (the only notable difference was the number of alcohol consumers (5% in the non-protective ventilation group, 10.5% in the protective group).
A modified intention to treat analysis was used, with relevant follow-up of all patients for the duration of the study. Three patients were excluded after randomisation (two due to extensive illness and surgery less than two hours, one due to exclusion criteria violation), and a further three patients were recruited and randomised.
A total of 400 participants were recruited -prior to the study it was calculated that for a power of 80% to detect a 50% relative difference in primary outcome, with a twosided alpha level of 0.05, 400 participants would be required.
The protocol, which was produced a priori and centrally registered, clearly dictated what constituted protective versus non-protective ventilation. Analysis of baseline characteristics allowed for adjustment where appropriate.
Do the statistical tests correctly test the results to allow
differentiation of statistically significant results? Yes. Primary outcomes were analysed using unadjusted chi-square analysis. Relevant baseline co-variates and stratification variables were identified using multiple logistic regression analysis, with a Poisson generalised linear model regression used to perform adjusted analyses. Binary secondary outcomes were analysed using chi-square or Fischer' s exact test (where appropriate). Continuous secondary outcomes were measured using unpaired t-test or Mann-Whitney U test. Adjusted analyses for both binary and continuous outcomes were performed using the same variables used in the linear regression model. Data relating to primary outcomes were complete, though data for secondary outcomes were incomplete, missing pH, PaO 2 , PaCO 2 , HCO 3 and SaO 2 in a large number of cases (noted in Table S5 of the supplementary appendix).
Multiple imputation was used to facilitate statistical analysis of the data. 3. Are the conclusions valid in light of the results? Yes. The adjusted relative risk reductions of 0.40 (95% CI 0.24-0.68) of composite primary outcomes and 0.45 (95% CI 0.28-0.73) of composite secondary outcomes in the protective ventilation group support the conclusion that prophylactic lung-protective ventilation reduces postoperative complications, although when the authors state 'surgery' it would be more correct to consider this as evidence of benefit in abdominal surgery. 4. Did any results get omitted and why? No. The trial was centrally registered (NCT01282996) with a pre-specified protocol and outcomes. All results were reported (accepting the impact of data for which multiple imputation was used). 5. Did the authors suggest any areas for further research? No. 6. Did they make any recommendations based on the results and were they appropriate? Partially. The authors conclude that their study provides evidence that prophylactic lungprotective ventilation reduces postoperative complications and healthcare utilisation, and the defence of the study limitations implies that they recommend lung-protective ventilation. However, the exclusion criterion of preoperative risk index of pulmonary complications ≤2 led to the exclusion of 1,053 patients from 1,803 potential participants. The majority of the patients initially identified in the study were thus at low risk of pulmonary complications, and it remains to be seen if the benefits (particularly reduced pulmonary complications) of the protective ventilation strategy used in the study would translate to the low risk population.
Patients at higher risk of pulmonary complications are seen to benefit from protective ventilation, and the results of this study support a default position of protective ventilation unless otherwise indicated. 7. Is this study relevant to my clinical practice? Yes.
Opportunities to reduce harm to patients incurred during elective surgery with little or no demands on increasing resources are to be commended. In addition, the evidence suggesting a decrease in hospital stay (if borne out) would enable resources to be used for other patients. 8. What level of evidence does this study represent? 1B, but confidence intervals are fairly wide. 9. What grade of recommendation can I make on this result alone? Grade 1 (CEBM). A large positive effect regarding the primary outcomes was noted (adjusted relative risk of lung-protective ventilation group 0.40, 95% CI 0.24-0.68 when compared to non-lung-protective ventilation) that was statistically significant (p=0.001). Secondary outcomes again showed a marked positive difference, with both clinical and statistical significance (relative risk 0.29, 95% CI 0.14-0.61, p=0.001). 10.What grade of recommendation can I make when this study is considered along with other available evidence? Grade 1 (CEBM). Other level 1 studies have displayed reduction of harmful outcomes by employing lung-protective ventilation strategies. 1 11.Should I change my practice because of these results? Yes. The results of the study show favourable outcomes for those patients at higher risk of pulmonary complications when a lung-protective ventilation strategy is used, but does not consider those at lower risk. High-risk patients should receive lung-protective ventilation, with consideration of such a strategy given to low-risk patients. 12.Should I audit my current practice? No. No specific audit is indicated by the study. 
